Evidence map›Paper›PMID 30305101›Full record

ArticleMalaria journal2018

Dynamics of Plasmodium falciparum gametocyte carriage in pregnant women under intermittent preventive treatment with sulfadoxine-pyrimethamine in Benin.

Sayeh Jafari-Guemouri, Jamila Dhiab, Achille Massougbodji, Philippe Deloron, Ndam N Tuikue

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Prevalence ofPathogens (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Investigating the dynamics ofOpen research Europe · 2025
    Article
  4. Article
  5. Biology and epidemiology ofParasite epidemiology and control · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Sayeh Jafari-GuemouriUMR 216 Mère et Enfant Face aux Infections Tropicales, Institut de Recherche pour le Développement (IRD), 4, Avenue de l'Observatoire, 75270, Paris, France. sayeh.guemouri@ird.fr.ORCID http://orcid.org/0000-0002-8424-332X
Jamila DhiabUMR 216 Mère et Enfant Face aux Infections Tropicales, Institut de Recherche pour le Développement (IRD), 4, Avenue de l'Observatoire, 75270, Paris, France.
Achille MassougbodjiCentre d'Etude et de Recherche pour le Paludisme associé à la Grossesse et à l'Enfance, Faculté des Sciences de Santé, Université d'Abomey-Calavi, 01 BP 188, Cotonou, Benin.
Philippe DeloronUMR 216 Mère et Enfant Face aux Infections Tropicales, Institut de Recherche pour le Développement (IRD), 4, Avenue de l'Observatoire, 75270, Paris, France.
Ndam N TuikueUMR 216 Mère et Enfant Face aux Infections Tropicales, Institut de Recherche pour le Développement (IRD), 4, Avenue de l'Observatoire, 75270, Paris, France.
Délégation Paris 5 · FRNoguchi Memorial Institute for Medical Research · GHUniversité d'Abomey-Calavi · BJ

Funding

European 7th Framework Programme 200889European 7th Framework Programme 304815
6 · The paper itself

Abstract

backgroundIn sub-Saharan Africa, malaria is a major cause of morbidity and mortality, in particular in children and pregnant women. During pregnancy, Plasmodium falciparum infected red blood cells expressing VAR2CSA are selected from circulation by selective cytoadherence to chondroitin sulfate proteoglycan receptors expressed in the placenta, leading to an increased susceptibility to malaria, long-lasting infections and poor pregnancy outcome. Partly because of these long-lasting infections, women were reported to have a higher density of gametocytes in their peripheral blood, and are considered as a potential reservoir for malaria transmission. To improve pregnancy outcome in areas of high malaria transmission, The WHO recommends intermittent preventive treatment with sulfadoxine/pyrimethamine (IPTp-SP) during antenatal care visits. The effect of IPTp-SP on gametocyte carriage in infected pregnant women was studied.

methodsThe levels of transcription of three gametocytes stage-specific genes Pfs16 (expressed by sexually-committed ring stage parasites and fully matured gametocytes), Pfs25 (expressed by female mature gametocytes) and Pfs230 (expressed by male mature gametocytes) were assessed by real-time PCR in 50 P. falciparum infected women at early pregnancy (before implementation of IPTp-SP), and in 50 infected women at delivery. Sex ratios of male and female gametocytes were determined in these women to assess the effect of IPTp-SP on the gametocyte populations.

resultsThe data show that the three transcript types specific to Pfs16, Pfs25 and Pfs230 were detected in all samples, both at inclusion and delivery. Levels of Pfs25 and Pfs230 transcripts were higher at delivery than at inclusion (p = 0.042 and p = 0.003), while the opposite was observed for Pfs16 (p = 0.048). The ratio of male/female gametocyte transcript levels was higher at delivery than at inclusion (p = 0.018). Since a mixed gender late stage gametocyte culture was used as a positive control, male and female gametocytes could not be quantified in an absolute way in the samples. However, the amplification reliability of the Pfs25 and Pfs230 markers in the samples could be checked. A relative quantity of each type of Pfs transcript was, therefore, used to calculate the sex ratio proxy.

conclusionThis study demonstrates that IPTp-SP treatment contributes to modify the parasite populations' structure during pregnancy. In line with previous studies, we suggest that the continued use of SP in pregnant women as IPTp, despite having a beneficial effect on the pregnancy outcome, could be a risk factor for increased transmission. This reinforces the need for an alternative to the SP drug for malaria prevention during pregnancy.

Indexed as

AdolescentAdultAntigens, ProtozoanAntimalarialsBeninDrug CombinationsFemaleHumansMalaria, FalciparumMembrane ProteinsPlasmodium falciparumPregnancyProtozoan ProteinsPyrimethamineReal-Time Polymerase Chain ReactionReproducibility of ResultsAntigens, ProtozoanAntimalarialsDrug Combinationsfanasil, pyrimethamine drug combinationMembrane ProteinsPfs16 protein, Plasmodium falciparumPfs230 antigen, Plasmodium falciparumPfs25 protein, Plasmodium falciparumProtozoan ProteinsPyrimethamineSulfadoxineGametocytesIntermittent preventive treatmentMalariaMalaria transmissionPlasmodium falciparumPregnant women

Identifiers

PMID30305101
PMCPMC6180446
OpenAlexW2896777573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.